[Deep Brain Stimulation of Globus Pallidus]

Area of Science:

• Neurosurgery
• Neurology
• Movement Disorders

Background:

• Deep brain stimulation (DBS) is a therapeutic option for advanced Parkinson's disease (PD).
• The globus pallidus internus (GPi) and subthalamic nucleus (STN) are primary targets for DBS in PD.
• Optimal surgical targeting involves image-based guidance and intraoperative microelectrode recording (MER).

Purpose of the Study:

• To evaluate the efficacy of GPi DBS as a target for Parkinson's disease.
• To compare GPi DBS with STN DBS in managing hyperkinetic movement disorders and medication reduction.
• To identify patient subgroups that may benefit most from GPi DBS.

Main Methods:

• Surgical implantation of DBS electrodes in the GPi.
• Intraoperative microelectrode recording (MER) and stimulation for target refinement.
• Assessment of motor symptoms, dyskinesia, and medication requirements post-surgery.

Main Results:

• GPi stimulation effectively impacts intractable hyperkinetic movement disorders.
• STN stimulation is globally preferred for PD DBS and shows greater medication reduction.
• GPi stimulation provides a direct anti-dyskinetic effect, independent of levodopa dosage.

Conclusions:

• GPi DBS is a viable option for managing hyperkinetic movement disorders in PD.
• GPi stimulation may be particularly beneficial for patients with neurocognitive or neuropsychiatric comorbidities.
• While STN remains the preferred target for most PD patients, GPi offers distinct advantages for select individuals.